Back to Results
First PageMeta Content
Lactams / Lactones / Pfizer / Piperidines / Prodrugs / Medicine / Oncology / Irinotecan


Systems Pharmacology Identification of Tumour Nanoparticle Permeability as Predictor of Clinical AntiCancer Activity of MM-398, Nanoliposomal Irinotecan, nalIRI Fitzgerald, Jonathan1; Korn Ron2; Fetterly, Gerald3; Sachde
Add to Reading List

Document Date: 2014-09-08 00:30:36

Open Document

File Size: 123,54 KB

Share Result on Facebook

City

Tucson / Buffalo / Cambridge / /

Company

Ramesh4 1 Merrimack Pharmaceuticals Inc. / /

Country

United States / /

Facility

3Roswell Park Cancer Institute / Arizona Cancer Center / /

IndustryTerm

magnetic resonance imaging / tumour nanoparticle permeability using magnetic resonance imaging / /

MedicalCondition

cancer / tumour / refractory solid tumours / tumours / /

MedicalTreatment

chemotherapy / /

Organization

3Roswell Park Cancer Institute / Piper Cancer Center / Arizona Cancer Center / /

Technology

magnetic resonance imaging / MRI / chemotherapy / /

SocialTag